3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
16
Carcinoma, Intraductal, Noninfiltrating
4
Breast Carcinoma In Situ
4
Ovarian Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdomyosarcoma
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lung Neoplasms
1
Liver Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Fibrosarcoma
1
Fatigue
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Interventions
spartalizumab
2
durvalumab
2
zanidatamab
1
tremelimumab
1
trastuzumab deruxtecan
1
tislelizumab
1
pembrolizumab
1
obinutuzumab
1
naptumomab estafenatox
1
Trastuzumab
1
Polymerase Chain Reaction
1
Nivolumab
1
Mass Spectrometry
1
In Situ Hybridization, Fluorescence
1
Immunohistochemistry
1
Gemcitabine
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
Ado-Trastuzumab Emtansine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Mass Spectrometry
×
Breast
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled